1. Abe T, Kazama M, Naito I, Ueda M, Tanaka T, Higuchi H, Saso S, Kariyone S, Yoshimura M, Maekawa T, Morimatsu M, Moriyasu N, Takagi S, Maezawa H, Kase M, Kuwana N, Odakura T, Takasu K, Sugawara Y, Takahashi A, Okubo M, Ijichi H, Yamamoto S, Kikuchi H, Kito S, Tokito S, Iwasaki Y (1981a) Clinical evaluation for efficacy of tissue culture urokinase (TCUK) on cerebral thrombosis by means of multicenter double-blind study. Blood Vessel 12:321–341
2. Abe T, Kazawa M, Naito I, Kanaya H, Machino R, Igata A, Tazaki Y, Kameyama M, Goto F, Maezawa H, Watanabe H, Urushiyama K, Togi H, Sakuragawa N, Atarashi J, Kito S, Araki G, Onodera H, Otomo E, Ogawa N (1981b) Clinical effect of urokinase (60 000 units/day) on cerebral infarction — Comparative study by means of multiple center double blind test. Blood Vessel 12:342–358
3. Abe T, Machii K, Kajiwara N, Kawai C, Kanmatsuse K, Kanbara H, Nobuyoshi M, Yamaguchi T, Osada H, Kawada H, Matsuo O (1989) Clinical usefulness of intravenous application of SM-9527 (duteplase; t-PA) in acute myocardial infarction: A multicentered, double-blind comparative study with intravenous administration of urokinase. Clin Eval 17:485–515
4. Abe T, Terashi A, Tohgi H, Sasoh S, Naito I (1990) Clinical efficacy of intravenous administration of SM-9527 (t-PA) in cerebral thrombosis. Clin Eval 18:39–69
5. Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W (1996) Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 27:1711–1718